Table 2.
Survival analysis of prognostic factors in ND patients with B‐NHL
| Factor | Survival analysis of ND patients | |
|---|---|---|
| Number | log‐rank p value | |
| Age (y) | ||
| ≤65 | 8 | 0.063 |
| >65 | 8 | |
| Gender | ||
| Male | 10 | 0.875 |
| Female | 6 | |
| B syndromes | ||
| No | 10 | 0.014 |
| Yes | 6 | |
| LDH levels | ||
| ≤678 | 13 | <0.001 |
| >678 | 3 | |
| IPI score | ||
| 0–4 | 11 | 0.027 |
| >4 | 3 | |
| Ann Arbor stage | ||
| I–III | 6 | 0.081 |
| IV | 7 | |
| M‐MDSC% | ||
| ≤28.49 | 11 | 0.148 |
| >28.49 | 5 | |
| G‐MDSC% | ||
| ≤98.70 | 11 | 0.005 |
| >98.70 | 3 | |
Note: MDSC level (high/low) is based on the maximally selected rank statistics. Bold values are statistically significant.
Abbreviations: B‐NHL, B‐cell non‐Hodgkin lymphoma; G‐MDSC, granulocyte myeloid‐derived suppressor cells; IPI, International Prognostic Index; LDH, lactic dehydrogenase; M‐MDSC: monocyte MDSC; ND, newly diagnosed.